AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 53(2), 1995, pp. 202-205
Copyright © 1995 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abramo, C.
Right arrow Articles by Krettli, A. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abramo, C.
Right arrow Articles by Krettli, A. U.

Cross-Reactivity between Antibodies in the Sera of Individuals with Leishmaniasis, Toxoplasmosis, and Chagas' Disease and Antigens of the Blood-Stage forms of Plasmodium falciparum Determined by Indirect Immunofluorescence

Clarice Abramo, Cor Jesus F. Fontes AND Antoniana U. Krettli
Centro de Pesquisas Rene Rachou, Fundacao Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil; Universidade Federal de Mato Grosso; Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

Seroepidemiologic studies using the indirect immunofluorescent antibody test (IFAT) are valuable in malaria control programs in identifying local foci of malaria, in diagnosing malaria in asymptomatic, low-parasitemia blood donors in nonendemic countries, in detecting imported malaria and preventing its introduction into new areas, and in excluding recurrent fever from causes other than malaria. Because other diseases may occur in areas where malaria is prevalent, the aim of this work, using the IFAT, was to determine the frequency of cross-reactions between blood-stage antigens of Plasmodium falciparum and antibodies present in the serum of individuals with leishmaniasis, toxoplasmosis and Chagas' disease. Since malaria transmission does not occur in the study area (State of Minas Gerais, Brazil) where these other diseases are present, we studied sera from individuals living in this area who had never been in the areas endemic for malaria in the Amazon region. Positive reactivity of sera with blood malaria antigens evaluated by IFAT at dilutions ≥ 1:40 was detected in 19 (38%) of 50 individuals with cutaneous leishmaniasis, five (62%) of eight individuals with visceral leishmaniasis, 14 (32%) of 44 individuals with Chagas' disease, four (11%) of 36 individuals with toxoplasmosis, and in none of the 14 uninfected controls. All 23 of the control malaria sera from the endemic area (State of Mato Grosso, Brazil) were positive at high dilutions. We found no correlation between titers of the IFAT with malaria and the specific antigens used for serodiagnosis of the other protozoan infections studied. At dilutions of 1:20 and 1:40, the sensitivity of the IFAT test was 100% and specificity was 52% and 72%, respectively. At a dilution of 1:80, the sensitivity was 86% and the specificity was 90%. Thus, the choice of the final dilution of serum for use for the diagnosis of malaria should take into account the study population and the type of parasites prevalent in the area. At the present time, leishmaniasis is endemic in many areas of the Amazon region where malaria is endemic. Thus, we recommend the use of sera diluted ≥ 1:80 to exclude cross-reactive antibodies to this parasite in seroepidemiologic studies of malaria.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society of Tropical Medicine and Hygiene.